Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K33/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.3141249PHARMACEUTICAL COMPOSITION FOR TREATING A GLYCOPROTEIN-RELATED DISEASE
EP 15.03.2017
Int.Class A61K 31/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
095Sulfur, selenium or tellurium compounds, e.g. thiols
10Sulfides; Sulfoxides; Sulfones
Appl.No 16184199 Applicant LU MING CHANG Inventor LU MING-CHANG
A method for treating a glycoprotein-related disease is disclosed, which comprises: administering a first effective amount of phenol red and a second effective amount of an organic arsenic compound to a subject in need thereof.
2.WO/2005/074990METHODS OF PREVENTING AND TREATING SARS USING LOW PH RESPIRATORY TRACT COMPOSITIONS
WO 18.08.2005
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/US2005/003172 Applicant THE PROCTER & GAMBLE COMPANY Inventor RENNIE, Paul, John
The present invention is directed to methods of preventing and treating Severe Acute Respiratory Syndrome (SARS) by the administration of respiratory tract compositions having low pH values. The respiratory tract compositions have a pH of from about 3.0 to about 5.5, and are preferably administered to areas of the respiratory tract such as the nasal cavity to effectively prevent and treat respiratory tract viral infections, particularly SARS. The respiratory tract compositions comprise an organic acid in combination with a metal compound.
3.WO/2005/013980USE OF INDOMETHACIN AND DERIVATIVES AS BROAD-SPECTRUM ANTIVIRAL DRUGS AND CORRESPONDING PHARMACEUTICAL COMPOSITIONS.
WO 17.02.2005
Int.Class A61K 31/315
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
28Compounds containing heavy metals
315Zinc compounds
Appl.No PCT/EP2004/051773 Applicant UNIVERSITA' DEGLI STUDI DI ROMA 'TOR VERGATA' Inventor SANTORO, Maria, Gabriella
Object of the present invention is the use of indomethacin (INDO) and its derivatives and salts as antiviral drugs, since it was found that INDO is able to stimulate an antiviral defense response in cells attacked by viruses. This antiviral response has been found in the presence of INDO alone and/or in combination with other compounds, for instance with metals and metal-containing compounds, Prostanoids and antiviral drugs. In combination with these compounds INDO develops an unexpected as well as effective synergic antiviral action.
4.WO/2007/120556ANTIVIRAL METHODS
WO 25.10.2007
Int.Class A61K 33/34
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
34Copper; Compounds thereof
Appl.No PCT/US2007/008439 Applicant AGION TECHNOLOGIES, INC. Inventor TROGOLO, Jeffrey, A.
Combinations of silver and copper ion sources or a single source of both silver and copper ions are found effective in methods for treating viral infections and for treating surfaces so as to eradicate viral contaminants and/or prevent subsequent contamination of said surfaces with viruses. These methods are particularly applicable in addressing SARS and avian flu viruses.
5.2004359653METHOD FOR TREATMENT AND PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) WITH DEUTERIUM-DECREASED WATER (SUPERLIGHT WATER)
JP 24.12.2004
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
Appl.No 2003193198 Applicant INTERNATL SCIENT:KK Inventor USUI TATSUO

PROBLEM TO BE SOLVED: To provide an effective method for the treatment and prevention of severe acute respiratory syndrome (SARS) to which effective treatment is not yet developed and the present treatment is the transfer to a hospital to leave a patient to spontaneous healing and for which preventing method is lacked except for the wearing of mask, washing of hands, gargling, sterilization, or the like.

SOLUTION: Severe acute respiratory syndrome (SARS) is treated and prevented by enhancing immunological competence by lowering the heavy water concentration in the body by using a deuterium-decreased water (superlight water).

COPYRIGHT: (C)2005,JPO&NCIPI

6.20050008535Noble gas-chlorine mixture effective against micro organisms
US 13.01.2005
Int.Class A01N 1/00
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
1Preservation of bodies of humans or animals, or parts thereof
Appl.No 10613943 Applicant Inventor Globus Alfred R.

A noble gas-chlorine gas mixture having broad-spectrum effectiveness against bacteria, viruses, mold, fungi, algae including spore forming microorganisms, termites, roaches, mice and other organisms. The noble gas, preferably argon/chlorine gas mixture (Chloragon) is introduced into an enclosed area where the bacteria, virus, mold, fungi, etc., are found and allowed to remain so that the gas composition can penetrate completely into the space including cracks and crevices. After the remediation is complete, the enclosed space should be ventilated or air movement increased to disperse the remaining gas composition.

7.20100196285Use of Deuterium Oxide to Treat Virus-Based Diseases of the Respiratory Tract
US 05.08.2010
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
Appl.No 12652939 Applicant BAYERL THOMAS Inventor Bayerl Thomas

The present invention relates to the use of deuterium oxide for the prophylaxis and/or therapy of virus-based diseases of the respiratory tract.

8.101085811SARS coronavirus pharmaceutical target and application thereof
CN 12.12.2007
Int.Class C07K 14/165
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
165Coronaviridae, e.g. avian infectious bronchitis virus
Appl.No 200610027476.X Applicant Shanghai Institutes for Biological Sciences, CAS Inventor Sun Bing
The invention relates to a medicinal target point for SARS coronavirus and its application. The medicinal target point is protein coded by ORF3a virus gene, possesses ion channel property, the amnio acid squence is SEQ ID NO: 1 or its derivant aquence. The invention aslo provides the monoclonal antibody and multiple antibody of said medicinal target point and the preparation method, and a kind of inhibitive agent for virus.
9.WO/2007/033444ANTIVIRAL THERAPY WITH CARBOHYDRATE BINDING AGENTS
WO 29.03.2007
Int.Class A61K 31/409
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
409having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
Appl.No PCT/BE2006/000104 Applicant K.U. LEUVEN RESEARCH AND DEVELOPMENT Inventor BALZARINI Jan
The field of the invention relates to the use of carbohydrate binding compounds as a medicine, their use to treat or prevent viral infections, their use to manufacture a medicine to treat or prevent viral infections and their use in a vaccination strategy. The present invention relates to the use of said compounds to manufacture a medicine to treat or prevent viral infections of subjects, more in particular infections with viruses having glycosilated envelop proteins such as Retroviridae (i.e. Lentivirinae), like HIV (human immunodeficiency virus), Flaviviridae, like HCV (hepatitis C virus), Hepadnaviridae, like HBV (hepatitis B virus), Coronaviridae, like SARS corona virus, and Orthomyxoviridae, like influenza A, B or C.
10.WO/2005/094869COMPOSITIONS AND METHODS FOR IMPROVED MUCUS FUNCTION
WO 13.10.2005
Int.Class A61K 31/721
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716Glucans
721Dextrans
Appl.No PCT/CA2005/000463 Applicant KING, Malcolm Inventor KING, Malcolm
The invention relates to compositions and methods for enhancing mucus functions such as but not limited to improved respiratory tract mucus clearance. The compositions of the invention are mucothickening compositions. They can be used to improve mucus clearance in a subject in need thereof, such as in the treatment of conditions related to non-functioning cilia or to excessively thin mucus.